Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib

Clinical trial NCT02538627 · TERMINATED

Trial details

NCT number: NCT02538627
Sponsor: Merrimack Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Colorectal Cancer Non-small Cell Lung Cancer Squamous Cell Carcinoma of the Head and Neck

Start date: 2015-08-01
Primary completion: 2016-10-05
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.